CJC-1295 with DAC (2mg)

CJC-1295 with DAC (2mg) is a synthetic growth hormone-releasing peptide engineered to support sustained growth hormone stimulation and prolonged activity compared to traditional GHRH analogs. Through its interaction with growth hormone-releasing hormone (GHRH) receptors, it promotes increased secretion of growth hormone and IGF-1—key factors involved in muscle development, fat metabolism, cellular regeneration, and recovery.

What sets CJC-1295 with DAC apart is its Drug Affinity Complex (DAC) technology, which extends the peptide’s half-life and allows for a more consistent, long-lasting release. This extended activity makes it particularly valuable in research focused on long-term growth hormone modulation and metabolic function.

In research settings, CJC-1295 with DAC has been studied for its potential role in supporting improved body composition, enhanced recovery, cellular repair, and broader investigations into healthy aging and performance optimization. Its sustained mechanism of action also makes it a compelling candidate for studies exploring hormonal balance and regenerative processes.

For researchers seeking a high-quality peptide for growth hormone-related studies, CJC-1295 with DAC (2mg) offers a potent and dependable option for advancing scientific exploration.